Response Adaptive Block Randomization (RABR) is a new method for clinical trials that helps assign patients to different treatment groups based on how well each group is performing. This method allows for more control over how patients are assigned, making it easier to reach the desired number of participants and increase the accuracy of the results. RABR has been shown to be more effective than other common methods in reaching these goals, as demonstrated by statistical simulations and real-world examples.